179 related articles for article (PubMed ID: 21206182)
1. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of monomorphic primary central nervous system post-transplantation lymphoproliferative disorder 5 years after kidney transplantation.
Yaginuma T; Yamamoto H; Mitome J; Tanno Y; Yamamoto I; Kobayashi A; Mafune A; Hayakawa H; Yokoyama K; Mori R; Ohashi H; Kaito N; Joki T; Miki J; Yamada H; Furuta N; Matsushima S; Fukuda T; Hosoya T
Transpl Infect Dis; 2012 Oct; 14(5):E102-6. PubMed ID: 22931101
[TBL] [Abstract][Full Text] [Related]
3. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
Funch DP; Ko HH; Travasso J; Brady J; Kew CE; Nalesnik MA; Walker AM
Transplantation; 2005 Nov; 80(9):1174-80. PubMed ID: 16314782
[TBL] [Abstract][Full Text] [Related]
7. [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].
Minauchi K; Koizumi K; Kondo M; Takigami M; Harada H; Fujita H; Mukai M
Rinsho Ketsueki; 2011 May; 52(5):272-7. PubMed ID: 21646772
[TBL] [Abstract][Full Text] [Related]
8. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
[TBL] [Abstract][Full Text] [Related]
9. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
[TBL] [Abstract][Full Text] [Related]
10. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
Gheorghe G; Radu O; Milanovich S; Hamilton RL; Jaffe R; Southern JF; Ozolek JA
Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
[TBL] [Abstract][Full Text] [Related]
11. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
[TBL] [Abstract][Full Text] [Related]
12. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
15. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
Patil R; Prashar R; Patel A
Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
18. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
19. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report.
Gao R; Zhang Y; Chen G; Bhekharee AK; Du Z; Chu S
Medicine (Baltimore); 2021 Feb; 100(6):e24713. PubMed ID: 33578612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
